LAUREN MEYER: Open Payments
NPI 1942889563 · MERRIAM, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 32 payments from 17 companies in 2025. Trend: 2023 $2,035 · 2024 $1,489 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 4 | $109 |
| GENZYME CORPORATION | 4 | $102 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| ABBVIE INC. | 2 | $46 |
| Exact Sciences Corporation | 2 | $31 |
| JAZZ PHARMACEUTICALS INC. | 1 | $21 |
| Viatris Specialty LLC | 1 | $21 |
| Agios Pharmaceuticals, Inc. | 1 | $20 |
Products named: DUPIXENT, QULIPTA, NUCALA, XYWAV, YUPELRI, FASENRA, TRELEGY ELLIPTA, PYRUKYND.
Industry payments across KS — which companies pay providers there.
